LGALS1 and neoplasm: Among these, LGALS1 expression levels showed a significant positive correlation with tumor cell sensitivity to four agents – zoledronate, staurosporine, JNJ-38877605, and pazopanib – indicating that higher LGALS1 might render tumors more susceptible to these drugs.